47045-BFA-T-PADS-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Scaling-up of high impact interventions in the fight against TB based on the STOP TB strategy - Burkina Faso (01-Jul-2015-31-Dec-2017)</narrative> Burkina Faso, Tuberculosis, Programme d'Appui au Développement Sanitaire (PADS) Goal: Reduce TB prevalence from 80 cases per 100,000 population in 2013 to 72 cases per 100,000 population in Burkina Faso by the end 2017. Objectives: Decrease TB/HIV co-infection related deaths from 19.6% (2013 cohort) to less than 5% by the end of 2017 (2016 cohort); Improve program management and strategic information availability; Increase treatment success rate of MDR-TB cases from 57.7% (2012 cohort) to at least 75% by end of 2017 (2016 cohort); Increase treatment success rate of TB cases in all forms from 79.8% (2013 cohort) to at least 90% by end of 2017 (2016 cohort). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Lilian Pedrosa Fund Portfolio Manager +41 58 791 1700 lilian.pedrosa@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Burkina Faso Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases 2174221.91 Global Fund commitment to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 31101.91 Global Fund disbursement to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 747275.89 Global Fund disbursement to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -14125.98 Global Fund commitment to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 14125.98 Funds returned to the Global Fund from BFA-T-PADSP01. Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria 592827.65 Global Fund disbursement to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 527389.67 Global Fund disbursement to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 27536.00 Global Fund disbursement to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -248090.78 Global Fund commitment to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 2610304.03 Global Fund commitment to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 30895.39 Global Fund disbursement to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 800829.25 Global Fund disbursement to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 139137.38 Global Fund disbursement to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 827471.82 Global Fund disbursement to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 110197.70 Global Fund disbursement to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 107035.19 Global Fund disbursement to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 26696.32 Global Fund disbursement to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 91122.20 Global Fund disbursement to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 272681.75 Funds returned to the Global Fund from BFA-T-PADSP01. Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria 526452.52 Global Fund commitment to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -476918.78 Global Fund commitment to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 258057.37 Global Fund disbursement to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -272681.75 Global Fund commitment to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 77398.19 Global Fund disbursement to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 38582.63 Global Fund disbursement to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 64678.68 Global Fund disbursement to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 28869.78 Global Fund commitment to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 28869.78 Global Fund disbursement to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -87735.66 Global Fund commitment to BFA-T-PADSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National. Aggregation: Non cumulative. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative> Module: MDR-TB. <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 285; Denominator: 578. Numerator: 223; Denominator: 223. Numerator: 205; Denominator: 254. Numerator: 245; Denominator: 245. Numerator: 245; Denominator: 245. Numerator: 151; Denominator: 237. Numerator: 268; Denominator: 268. Numerator: 83; Denominator: 221. Numerator: 268; Denominator: 268. Numerator: 199; Denominator: 235. <narrative>Number of TB cases (all forms) notified among key affected populations/high risk groups</narrative> Module: TB care and prevention. <narrative>Number of TB cases (all forms) notified among key affected populations/high risk groups</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 743; Denominator: 0; Percentage: 0%. Numerator: 458. Numerator: 89. Numerator: 901. Numerator: 901. Numerator: 221. Numerator: 1011. Numerator: 232. Numerator: 1011. Numerator: 476. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: National. Aggregation: Non cumulative. <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative> Module: TB care and prevention. <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 70; Denominator: 86. Numerator: 90; Denominator: 90. Numerator: 82; Denominator: 86. Numerator: 95; Denominator: 95. Numerator: 100; Denominator: 100. Numerator: 83; Denominator: 89. Numerator: 105; Denominator: 105. Numerator: 64; Denominator: 89. Numerator: 110; Denominator: 110. Numerator: 50; Denominator: 63. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Module: TB care and prevention. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 4245; Denominator: 5326. Numerator: 4976; Denominator: 5720. Numerator: 4672; Denominator: 5792. Numerator: 2825; Denominator: 3139. Numerator: 5649; Denominator: 6277. Numerator: 4540; Denominator: 5825. Numerator: 3089; Denominator: 3432. Numerator: 2462; Denominator: 3113. Numerator: 6178; Denominator: 6864. Numerator: 4436; Denominator: 5539. <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 18166; Denominator: 27629. Numerator: 45342; Denominator: 66680. Numerator: 0; Denominator: 0. Numerator: 52427; Denominator: 71817. Numerator: 53965; Denominator: 73925. Numerator: 38277; Denominator: 66366. Numerator: 58392; Denominator: 77857. Numerator: 37518; Denominator: 53864. Numerator: 60106; Denominator: 80141. Numerator: 33414; Denominator: 50782. <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 564; Denominator: 681. Numerator: 236; Denominator: 283. Numerator: 281; Denominator: 312. Numerator: 222; Denominator: 251. Numerator: 222; Denominator: 251. Numerator: 236; Denominator: 252. Numerator: 195; Denominator: 210. Numerator: 290. Numerator: 195; Denominator: 210. Numerator: 217; Denominator: 232. <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative> Module: TB/HIV. <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 5553; Denominator: 5792. Numerator: 3021; Denominator: 3083. Numerator: 2800; Denominator: 2886. Numerator: 3350; Denominator: 3384. Numerator: 3350; Denominator: 3384. Numerator: 2633; Denominator: 2793. Numerator: 3700; Denominator: 3700. Numerator: 2983; Denominator: 3164. Numerator: 3700; Denominator: 3700. Numerator: 2482; Denominator: 2505. 47045-BFA-T-PADS-2 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Scaling-up of high impact interventions in the fight against TB based on the STOP TB strategy - Burkina Faso (01-Jan-2018-31-Dec-2020)</narrative> Burkina Faso, Tuberculosis, Programme d'Appui au Développement Sanitaire (PADS) Goal: Réduire l'incidence des nouveaux cas et rechutes de 52 cas pour 100 000 habitants en 2015 à 35 cas pour 100 000 habitants au Burkina Faso d’ici fin 2022. Objectives: Augmenter le taux de succès au traitement des cas de tuberculose toutes formes confondues de 78,2% (cohorte 2015) à au moins 90% en fin 2022 (cohorte 2021); Augmenter le taux de succès du traitement des cas de TB-MR de 69,7% (cohorte 2015 régime court) à au moins 80% en fin 2022 (cohorte 2021 regime court); Diminuer le taux de décès chez les patients co-infectés TB/VIH de 17,3% (cohorte 2015) à moins de 5% en fin 2022 (cohorte 2021); Améliorer la gestion du Programme et la disponibilité de l’information stratégique. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Lilian Pedrosa Fund Portfolio Manager +41 58 791 1700 lilian.pedrosa@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Burkina Faso Tuberculosis Multicomponent, RSSH Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage Multicomponent -> Program management -> Coordination and management of national disease control programs Multicomponent -> Program management -> Grant management RSSH -> RSSH: Health management information systems and M&E -> Analysis, evaluations, reviews and transparency RSSH -> RSSH: Health management information systems and M&E -> Routine reporting RSSH -> RSSH: Health management information systems and M&E -> Surveys RSSH -> RSSH: Human resources for health, including community health workers -> Capacity building for health workers, including those at community level Tuberculosis -> MDR-TB -> Case detection and diagnosis (MDR-TB) Tuberculosis -> MDR-TB -> Prevention (MDR-TB) Tuberculosis -> MDR-TB -> Treatment (MDR-TB) Tuberculosis -> TB care and prevention -> Case detection and diagnosis (TB care and prevention) Tuberculosis -> TB care and prevention -> Key populations (TB care and prevention) - Others Tuberculosis -> TB care and prevention -> Key populations (TB care and prevention) - Prisoners Tuberculosis -> TB care and prevention -> Prevention (TB care and prevention) Tuberculosis -> TB care and prevention -> Treatment (TB care and prevention) Tuberculosis -> TB/HIV -> TB/HIV - Collaborative interventions 1782541.88 1677117.64 3643940.23 4373826.69 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 514422.29 Global Fund disbursement to BFA-T-PADSP02 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 22870.61 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 3026.08 Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 206385.41 Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 142296.58 Global Fund disbursement to BFA-T-PADSP02 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 147636.97 Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 320903.38 Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 507272.29 Global Fund disbursement to BFA-T-PADSP02 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 894.67 Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 253909.77 Global Fund disbursement to BFA-T-PADSP02 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 4592.75 Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 98490.17 Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 628619.02 Global Fund disbursement to BFA-T-PADSP02 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 47942.15 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -22870.61 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 24880.77 Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 428896.91 Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 161022.92 Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -955457.48 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 2976400.58 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 397498.64 Global Fund disbursement to BFA-T-PADSP02 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 2787.69 Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 25540.05 Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -2478.67 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -23061.38 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 25540.05 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 368107.36 Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 320988.04 Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 3488.97 Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 960012.20 Global Fund disbursement to BFA-T-PADSP02 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 25653.69 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 764820.42 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -923517.69 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 698483.20 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -764820.42 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 767717.54 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 431054.99 Global Fund disbursement to BFA-T-PADSP02 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 4311.49 Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 609056.76 Global Fund disbursement to BFA-T-PADSP02 (Pooled Procurement Mechanism). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 70227.29 Funds returned to the Global Fund from BFA-T-PADSP02 (Government). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -70227.29 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 23528.50 Global Fund disbursement to BFA-T-PADSP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 58517.06 Funds returned to the Global Fund from BFA-T-PADSP02 (Government). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -58517.06 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 89426.44 Global Fund disbursement to BFA-T-PADSP02 (Pooled Procurement Mechanism). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 4748.85 Funds returned to the Global Fund from BFA-T-PADSP02 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -4748.85 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 5338.79 Funds returned to the Global Fund from BFA-T-PADSP02 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -5338.79 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -332351.06 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 225196.87 Funds returned to the Global Fund from BFA-T-PADSP02 (Government). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -225196.87 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 75065.63 Funds returned to the Global Fund from BFA-T-PADSP02 (Government). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -75065.63 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 874.49 Funds returned to the Global Fund from BFA-T-PADSP02 (Government). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -874.49 Global Fund commitment to BFA-T-PADSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 1847202.21 Expenditure reported by Programme d'Appui au Développement Sanitaire (PADS) for BFA-T-PADSP02, Jan 2018 to Dec 2018. Programme d'Appui au Développement Sanitaire (PADS) 1677117.66 Expenditure reported by Programme d'Appui au Développement Sanitaire (PADS) for BFA-T-PADSP02, Jan 2019 to Dec 2019. Programme d'Appui au Développement Sanitaire (PADS) 2674079.52 Expenditure reported by Programme d'Appui au Développement Sanitaire (PADS) for BFA-T-PADSP02, Jan 2020 to Dec 2020. Programme d'Appui au Développement Sanitaire (PADS) 127253.07 Expenditure reported by Programme d'Appui au Développement Sanitaire (PADS) for BFA-T-PADSP02, Jan 2021 to Jun 2021. Programme d'Appui au Développement Sanitaire (PADS) <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 58. Numerator: 37; Denominator: 58; Percentage: 0.64%. Numerator: 4; Denominator: 58; Percentage: 0.07%. Numerator: 10; Denominator: 58; Percentage: 0.17%. Numerator: 48; Denominator: 58; Percentage: 0.83%. Numerator: 42. Numerator: 42. Numerator: 84. Numerator: 102; Percentage: 120%. Numerator: 52. Numerator: 33. Numerator: 105. Numerator: 74. Numerator: 65. Numerator: 25. Numerator: 131. Numerator: 68. Numerator: 68; Denominator: 68; Percentage: 100%. Numerator: 0; Denominator: 0. Numerator: 14; Denominator: 68; Percentage: 20.6%. Numerator: 54; Denominator: 68; Percentage: 79.4%. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 33; Denominator: 41; Percentage: 0.8%. Numerator: 23; Denominator: 33; Percentage: 0.7%. Numerator: 41. Numerator: 37; Denominator: 41; Percentage: 0.9%. Numerator: 4; Denominator: 41; Percentage: 0.1%. Numerator: 8; Denominator: 41; Percentage: 0.2%. Numerator: 33; Denominator: 41; Percentage: 0.8%. Numerator: 42. Numerator: 31. Numerator: 84. Numerator: 87; Percentage: 104%. Numerator: 52. Numerator: 35. Numerator: 105. Numerator: 59. Numerator: 65. Numerator: 19. Numerator: 131. Numerator: 60. Numerator: 60; Denominator: 60; Percentage: 100%. Numerator: 0; Denominator: 60; Percentage: 0%. Numerator: 11; Denominator: 60; Percentage: 18.3%. Numerator: 49; Denominator: 60; Percentage: 81.7%. Numerator: 60; Denominator: 60; Percentage: 100%. Numerator: 60; Denominator: 60; Percentage: 100%. <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative> Module: MDR-TB. <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 245; Denominator: 436. Numerator: 224; Denominator: 224. Numerator: 156; Denominator: 163. Numerator: 448; Denominator: 448. Numerator: 371; Denominator: 439. Numerator: 199; Denominator: 199. Numerator: 108; Denominator: 136. Numerator: 399; Denominator: 399. Numerator: 241; Denominator: 334. Numerator: 173; Denominator: 173. Numerator: 75; Denominator: 150. Numerator: 346; Denominator: 346. Numerator: 441; Denominator: 505. <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative> Module: TB care and prevention. <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 494. Numerator: 489; Denominator: 494. Numerator: 296. Numerator: 308. Numerator: 593. Numerator: 1047; Percentage: 120%. Numerator: 356. Numerator: 201. Numerator: 711. Numerator: 695. Numerator: 426. Numerator: 553. Numerator: 854. Numerator: 824. Numerator: 824. <narrative>Number of TB cases (all forms) notified among prisoners</narrative> Module: TB care and prevention. <narrative>Number of TB cases (all forms) notified among prisoners</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 19. Numerator: 10. Numerator: 22. Numerator: 23. Numerator: 65; Percentage: 120%. Numerator: 14. Numerator: 21. Numerator: 27. Numerator: 65. Numerator: 17. Numerator: 18. Numerator: 33. Numerator: 49. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 5671. Numerator: 5369; Denominator: 5671. Numerator: 187; Denominator: 5671. Numerator: 3805; Denominator: 5671. Numerator: 1625; Denominator: 5671. Numerator: 3931; Denominator: 5671. Numerator: 4595; Denominator: 5671. Numerator: 584; Denominator: 5671. Numerator: 492; Denominator: 5671. Numerator: 2912. Numerator: 2823. Numerator: 5825. Numerator: 5971; Percentage: 103%. Numerator: 3005. Numerator: 2832. Numerator: 6011. Numerator: 5916. Numerator: 3125. Numerator: 2149. Numerator: 6251. Numerator: 5920. Numerator: 5720; Denominator: 5920; Percentage: 96.6%. Numerator: 200; Denominator: 5920; Percentage: 3.4%. Numerator: 3838; Denominator: 5920; Percentage: 64.8%. Numerator: 1622; Denominator: 5920; Percentage: 27.4%. Numerator: 4298; Denominator: 5920; Percentage: 72.6%. Numerator: 4988; Denominator: 5920; Percentage: 84.3%. Numerator: 508; Denominator: 5920; Percentage: 8.6%. Numerator: 424; Denominator: 5920; Percentage: 7.2%. <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative> Module: TB care and prevention. <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 83; Denominator: 89. Numerator: 97; Denominator: 97. Numerator: 48; Denominator: 91. Numerator: 102; Denominator: 102. Numerator: 81; Denominator: 95. Numerator: 102; Denominator: 102. Numerator: 2; Denominator: 109. Numerator: 106; Denominator: 106. Numerator: 65; Denominator: 97. Numerator: 106; Denominator: 106. Numerator: 48; Denominator: 97. Numerator: 108; Denominator: 108. Numerator: 73; Denominator: 99. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Module: TB care and prevention. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 4320; Denominator: 5524. Numerator: 2684; Denominator: 3234. Numerator: 2360; Denominator: 2963. Numerator: 5368; Denominator: 6468. Numerator: 4627; Denominator: 5836. Numerator: 2475; Denominator: 2912. Numerator: 1283; Denominator: 1549. Numerator: 4951; Denominator: 5825. Numerator: 4917; Denominator: 5853. Numerator: 2614; Denominator: 3005. Numerator: 1943; Denominator: 2832. Numerator: 5228; Denominator: 6011. Numerator: 4601; Denominator: 5918. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 477; Denominator: 515. Numerator: 343; Denominator: 343. Numerator: 252; Denominator: 271. Numerator: 686; Denominator: 686. Numerator: 448; Denominator: 492. Numerator: 291; Denominator: 291. Numerator: 124; Denominator: 132. Numerator: 583; Denominator: 583. Numerator: 455; Denominator: 457. Numerator: 300; Denominator: 300. Numerator: 135; Denominator: 150. Numerator: 601; Denominator: 601. Numerator: 361; Denominator: 424. <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative> Module: TB/HIV. <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 5087; Denominator: 5671. Numerator: 2912; Denominator: 2912. Numerator: 2608; Denominator: 2963. Numerator: 5825; Denominator: 5825. Numerator: 5518; Denominator: 5971. Numerator: 3005; Denominator: 3005. Numerator: 1519; Denominator: 1614. Numerator: 6011; Denominator: 6011. Numerator: 5294; Denominator: 5916. Numerator: 3125; Denominator: 3125. Numerator: 2070; Denominator: 2149. Numerator: 6251; Denominator: 6251. Numerator: 5412; Denominator: 5920. 47045-BFA-T-PADS-3 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Scaling-up of high impact interventions in the fight against TB - Burkina Faso (01-Jan-2021-31-Dec-2023)</narrative> Burkina Faso, Tuberculosis, Programme d'Appui au Développement Sanitaire (PADS) Goals: Contribuer à l’amélioration de l’état de santé de la population du Burkina Faso en réduisant le poids de la tuberculose d’ici à fin 2025. To contribute to the improvement of the health status of the population of Burkina Faso by reducing the burden of tuberculosis by the end of 2025; Réduire l’incidence de la tuberculose de 48 en 2018 à 40 cas/100 000 habitants en 2025 et le taux de mortalité de 7,8 à 5,7 décès/100 000 habitants d’ici à fin 2025. Reduce the incidence of tuberculosis from 48 in 2018 to 40 cases/100,000 inhabitants in 2025 and the mortality rate from 7.8 to 5.7 deaths/100,000 inhabitants by the end of 2025. Objectives: Diagnostiquer et mettre sous traitement 40 641 malades TB de 2021 à 2025 avec une augmentation du taux de couverture du traitement de la TB (notifiés/incidence estimée) de 63% en 2018 à 90% en 2025. To diagnose and treat 40,641 TB patients from 2021 to 2025 with an increase in TB treatment coverage (reported/estimated incidence) from 63% in 2018 to 90% in 2025; Augmenter la proportion des nouveaux patients et rechutes de TB toutes formes ayant bénéficié du test Xpert MTB/RIF en diagnostic initial de 21 % en 2018 à 98% en 2025. To increase the proportion of new patients and relapses of all forms of TB having benefited from the Xpert MTB/RIF test in initial diagnosis from 21% in 2018 to 98% in 2025; Accroître le taux de succès au traitement des patients TB pharmaco sensibles de 79,1% (cohorte 2018) à au moins 90% (cohorte 2024) et ceux TB-résistante de 61,8% (cohorte 2018) à au moins 85% (cohorte 2024); Réduire le taux de décès chez les patients TB/VIH de 20% (cohorte 2018) à moins de 5% (cohorte 2024) . Reduce the death rate among TB/HIV patients from 20% (cohort 2018) to less than 5% (cohort 2024); Assurer le traitement antituberculeux à 100% des patients TB des zones à déficit sécuritaire. Ensuring 100% TB treatment for TB patients in unsafe areas; Renforcer les capacités du PNT dans la gestion de la lutte contre la tuberculose d’ici à fin 2025. Strengthen the capacity of the NTP in the management of tuberculosis control by the end of 2025. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Lilian Pedrosa Fund Portfolio Manager +41 58 791 1700 lilian.pedrosa@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Burkina Faso Tuberculosis Multicomponent, RSSH Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage Multicomponent -> Program management -> Coordination and management of national disease control programs Multicomponent -> Program management -> Grant management RSSH -> RSSH: Health management information systems and M&E -> Analysis, evaluations, reviews and transparency RSSH -> RSSH: Health management information systems and M&E -> Program and data quality RSSH -> RSSH: Health management information systems and M&E -> Routine reporting RSSH -> RSSH: Health management information systems and M&E -> Surveys Tuberculosis -> MDR-TB -> Treatment (MDR-TB) Tuberculosis -> TB care and prevention -> Case detection and diagnosis (TB care and prevention) Tuberculosis -> TB care and prevention -> Key Populations (TB care and prevention) - Children Tuberculosis -> TB care and prevention -> Treatment (TB care and prevention) Tuberculosis -> TB/HIV -> Collaborative activities with other programs and sectors (TB/HIV) Tuberculosis -> TB/HIV -> Community TB/HIV care delivery Tuberculosis -> TB/HIV -> Key populations (TB/HIV) - Miners and mining communities Tuberculosis -> TB/HIV -> Key populations (TB/HIV) - Mobile populations: refugees, migrants and internally displaced people Tuberculosis -> TB/HIV -> Key populations (TB/HIV) - Prisoners Tuberculosis -> TB/HIV -> TB/HIV - Collaborative interventions Tuberculosis -> TB/HIV -> TB/HIV - Prevention 2428707.20 5227946.65 3701767.57 6763681.56 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 474246.63 Global Fund disbursement to BFA-T-PADSP03 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 200373.60 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 942172.00 Global Fund disbursement to BFA-T-PADSP03 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 109395.63 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 23111.18 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 330971.05 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 70811.65 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 1111663.34 Global Fund disbursement to BFA-T-PADSP03 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 176924.68 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 206948.34 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 16233.01 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 102262.79 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 304278.74 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 100313.02 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 47650.69 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -23111.18 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 24597.42 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 89512.93 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 15132.83 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 255363.97 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 687894.25 Global Fund disbursement to BFA-T-PADSP03 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 269711.80 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 8167.37 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 8161.84 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 37249.77 Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria 3525144.57 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -1283142.11 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -37249.77 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 550651.49 Global Fund disbursement to BFA-T-PADSP03 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 79767.77 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 3308.88 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 3019.47 Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria 9.75 Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -3019.47 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 327124.13 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -9.75 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 396392.53 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 297101.24 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 63206.94 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 677.73 Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria 435592.79 Global Fund disbursement to BFA-T-PADSP03 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -677.73 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 435592.79 Global Fund disbursement to BFA-T-PADSP03 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 770976.45 Global Fund disbursement to BFA-T-PADSP03 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 140197.17 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 25232.39 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 35127.67 Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -35127.67 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 39223.11 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 1930465.03 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 12414.27 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 230831.38 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 12587.60 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 328857.75 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 25383.28 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -23053.27 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -2330.01 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 652911.91 Global Fund disbursement to BFA-T-PADSP03 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 107.77 Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria 26477.36 Global Fund disbursement to BFA-T-PADSP03 (Pooled Procurement Mechanism). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 797.14 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 72740.10 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -107.77 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 10360.57 Global Fund disbursement to BFA-T-PADSP03 (Pooled Procurement Mechanism). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 533.60 Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria 44.29 Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria 619324.88 Global Fund disbursement to BFA-T-PADSP03 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -44.29 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -533.60 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -2385.18 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 5742.97 Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -5742.97 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 34.47 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -25383.28 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 17647.38 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 8541.53 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 24720.23 Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -24720.23 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 8587.53 Global Fund disbursement to BFA-T-PADSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 37306.57 Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria 18102.86 Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -37306.57 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -18102.86 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -6508.52 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 72918.67 Funds returned to the Global Fund from BFA-T-PADSP03 (Government). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria 6508.52 Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria 1015.58 Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -72918.67 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -1015.58 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 73778.16 Funds returned to the Global Fund from BFA-T-PADSP03 (Government). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -73778.16 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 73778.16 Funds returned to the Global Fund from BFA-T-PADSP03 (Government). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -73778.16 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -774166.44 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 774166.44 Funds returned to the Global Fund from BFA-T-PADSP03 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria 73778.18 Funds returned to the Global Fund from BFA-T-PADSP03 (Government). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -73778.18 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -518.33 Global Fund commitment to BFA-T-PADSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 2428707.29 Expenditure reported by Programme d'Appui au Développement Sanitaire (PADS) for BFA-T-PADSP03, Jan 2021 to Dec 2021. Programme d'Appui au Développement Sanitaire (PADS) 3037111.56 Expenditure reported by Programme d'Appui au Développement Sanitaire (PADS) for BFA-T-PADSP03, Jan 2022 to Dec 2022. Programme d'Appui au Développement Sanitaire (PADS) 4401565.57 Expenditure reported by Programme d'Appui au Développement Sanitaire (PADS) for BFA-T-PADSP03, Jan 2023 to Dec 2023. Programme d'Appui au Développement Sanitaire (PADS) 310976.59 Expenditure reported by Programme d'Appui au Développement Sanitaire (PADS) for BFA-T-PADSP03, Jan 2024 to Jun 2024. Programme d'Appui au Développement Sanitaire (PADS) <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>2020 - Funding Request - Window 2b - TB/HIV - Burkina Faso - English</narrative> Funding Request of funding request FR940-BFA-C. <narrative>2020 - Funding Request - Window 2b - TB/HIV - Burkina Faso - Français</narrative> Funding Request of funding request FR940-BFA-C. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 74. Numerator: 72; Denominator: 74; Percentage: 97.3%. Numerator: 72; Denominator: 74; Percentage: 97.3%. Numerator: 72; Denominator: 74; Percentage: 97.3%. Numerator: 72; Denominator: 74; Percentage: 97.3%. Numerator: 72; Denominator: 74; Percentage: 97.3%. Numerator: 72; Denominator: 74; Percentage: 97.3%. Numerator: 2; Denominator: 74; Percentage: 2.7%. Numerator: 2; Denominator: 74; Percentage: 2.7%. Numerator: 2; Denominator: 74; Percentage: 2.7%. Numerator: 2; Denominator: 74; Percentage: 2.7%. Numerator: 2; Denominator: 74; Percentage: 2.7%. Numerator: 11; Denominator: 74; Percentage: 14.86%. Numerator: 11; Denominator: 74; Percentage: 14.86%. Numerator: 11; Denominator: 74; Percentage: 14.86%. Numerator: 11; Denominator: 74; Percentage: 14.86%. Numerator: 11; Denominator: 74; Percentage: 14.86%. Numerator: 11; Denominator: 74; Percentage: 14.86%. Numerator: 63; Denominator: 74; Percentage: 85.14%. Numerator: 63; Denominator: 74; Percentage: 85.14%. Numerator: 63; Denominator: 74; Percentage: 85.14%. Numerator: 63; Denominator: 74; Percentage: 85.14%. Numerator: 63; Denominator: 74; Percentage: 85.14%. Numerator: 63; Denominator: 74; Percentage: 85.14%. Numerator: 119. Numerator: 83. Numerator: 59. Numerator: 47; Percentage: 80%. Numerator: 47. Numerator: 0. Numerator: 9. Numerator: 38. Numerator: 60. Numerator: 36; Percentage: 60%. Numerator: 36. Numerator: 0. Numerator: 6. Numerator: 30. Numerator: 71. Numerator: 30. Numerator: 30. Numerator: 0. Numerator: 10. Numerator: 20. Numerator: 142. Numerator: 73. Numerator: 71. Numerator: 43. Numerator: 43. Numerator: 2. Numerator: 41. Numerator: 76. Numerator: 70. Numerator: 70. Numerator: 0. Numerator: 10. Numerator: 60. Numerator: 152. Numerator: 127. Numerator: 76. Numerator: 57. Numerator: 56. Numerator: 1. Numerator: 12. Numerator: 45. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 66. Numerator: 2; Denominator: 66; Percentage: 3.03%. Numerator: 2; Denominator: 66; Percentage: 3.03%. Numerator: 2; Denominator: 66; Percentage: 3.03%. Numerator: 2; Denominator: 66; Percentage: 3.03%. Numerator: 2; Denominator: 66; Percentage: 3.03%. Numerator: 2; Denominator: 66; Percentage: 3.03%. Numerator: 64; Denominator: 66; Percentage: 96.97%. Numerator: 64; Denominator: 66; Percentage: 96.97%. Numerator: 64; Denominator: 66; Percentage: 96.97%. Numerator: 64; Denominator: 66; Percentage: 96.97%. Numerator: 64; Denominator: 66; Percentage: 96.97%. Numerator: 64; Denominator: 66; Percentage: 96.97%. Numerator: 64; Denominator: 66; Percentage: 96.97%. Numerator: 64; Denominator: 66; Percentage: 96.97%. Numerator: 64; Denominator: 66; Percentage: 96.97%. Numerator: 64; Denominator: 66; Percentage: 96.97%. Numerator: 64; Denominator: 66; Percentage: 96.97%. Numerator: 55; Denominator: 66; Percentage: 83.33%. Numerator: 55; Denominator: 66; Percentage: 83.33%. Numerator: 55; Denominator: 66; Percentage: 83.33%. Numerator: 55; Denominator: 66; Percentage: 83.33%. Numerator: 55; Denominator: 66; Percentage: 83.33%. Numerator: 55; Denominator: 66; Percentage: 83.33%. Numerator: 59. Numerator: 42; Percentage: 71%. Numerator: 42. Numerator: 0. Numerator: 33. Numerator: 42. Numerator: 119. Numerator: 76. Numerator: 60. Numerator: 34; Percentage: 57%. Numerator: 34. Numerator: 0. Numerator: 28. Numerator: 34. Numerator: 71. Numerator: 29. Numerator: 29. Numerator: 0. Numerator: 20. Numerator: 29. Numerator: 142. Numerator: 67. Numerator: 71. Numerator: 38. Numerator: 38. Numerator: 36. Numerator: 35. Numerator: 152. Numerator: 113. Numerator: 76. Numerator: 64. Numerator: 64. Numerator: 0. Numerator: 54. Numerator: 60. Numerator: 76. Numerator: 49. Numerator: 48. Numerator: 1. Numerator: 38. Numerator: 49. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 5916. Numerator: 5737; Denominator: 5916; Percentage: 96.97%. Numerator: 5737; Denominator: 5916; Percentage: 96.97%. Numerator: 5737; Denominator: 5916; Percentage: 96.97%. Numerator: 5737; Denominator: 5916; Percentage: 96.97%. Numerator: 5737; Denominator: 5916; Percentage: 96.97%. Numerator: 5737; Denominator: 5916; Percentage: 96.97%. Numerator: 179; Denominator: 5916; Percentage: 3.03%. Numerator: 179; Denominator: 5916; Percentage: 3.03%. Numerator: 179; Denominator: 5916; Percentage: 3.03%. Numerator: 179; Denominator: 5916; Percentage: 3.03%. Numerator: 179; Denominator: 5916; Percentage: 3.03%. Numerator: 179; Denominator: 5916; Percentage: 3.03%. Numerator: 4733; Denominator: 5916; Percentage: 80%. Numerator: 4733; Denominator: 5916; Percentage: 80%. Numerator: 4733; Denominator: 5916; Percentage: 80%. Numerator: 4733; Denominator: 5916; Percentage: 80%. Numerator: 4733; Denominator: 5916; Percentage: 80%. Numerator: 4733; Denominator: 5916; Percentage: 80%. Numerator: 1479; Denominator: 5916; Percentage: 25%. Numerator: 1479; Denominator: 5916; Percentage: 25%. Numerator: 1479; Denominator: 5916; Percentage: 25%. Numerator: 1479; Denominator: 5916; Percentage: 25%. Numerator: 1479; Denominator: 5916; Percentage: 25%. Numerator: 1479; Denominator: 5916; Percentage: 25%. Numerator: 4437; Denominator: 5916; Percentage: 75%. Numerator: 4437; Denominator: 5916; Percentage: 75%. Numerator: 4437; Denominator: 5916; Percentage: 75%. Numerator: 4437; Denominator: 5916; Percentage: 75%. Numerator: 4437; Denominator: 5916; Percentage: 75%. Numerator: 4437; Denominator: 5916; Percentage: 75%. Numerator: 4837; Denominator: 5294; Percentage: 91.37%. Numerator: 4837; Denominator: 5294; Percentage: 91.37%. Numerator: 4837; Denominator: 5294; Percentage: 91.37%. Numerator: 4837; Denominator: 5294; Percentage: 91.37%. Numerator: 4837; Denominator: 5294; Percentage: 91.37%. Numerator: 4837; Denominator: 5294; Percentage: 91.37%. Numerator: 622; Denominator: 5916; Percentage: 10.51%. Numerator: 622; Denominator: 5916; Percentage: 10.51%. Numerator: 622; Denominator: 5916; Percentage: 10.51%. Numerator: 622; Denominator: 5916; Percentage: 10.51%. Numerator: 622; Denominator: 5916; Percentage: 10.51%. Numerator: 622; Denominator: 5916; Percentage: 10.51%. Numerator: 457; Denominator: 5294; Percentage: 8.63%. Numerator: 457; Denominator: 5294; Percentage: 8.63%. Numerator: 457; Denominator: 5294; Percentage: 8.63%. Numerator: 457; Denominator: 5294; Percentage: 8.63%. Numerator: 457; Denominator: 5294; Percentage: 8.63%. Numerator: 457; Denominator: 5294; Percentage: 8.63%. Numerator: 3151. Numerator: 3137; Percentage: 100%. Numerator: 3106. Numerator: 95. Numerator: 2082. Numerator: 798. Numerator: 2486. Numerator: 2788. Numerator: 147. Numerator: 266. Numerator: 6303. Numerator: 6739. Numerator: 3152. Numerator: 3602; Percentage: 114%. Numerator: 3483. Numerator: 119. Numerator: 2558. Numerator: 917. Numerator: 2685. Numerator: 3298. Numerator: 114. Numerator: 190. Numerator: 3394. Numerator: 3121. Numerator: 3001. Numerator: 118. Numerator: 2084. Numerator: 812. Numerator: 2307. Numerator: 2866. Numerator: 78. Numerator: 177. Numerator: 6788. Numerator: 6786. Numerator: 3394. Numerator: 3665. Numerator: 3555. Numerator: 110. Numerator: 2480. Numerator: 901. Numerator: 2764. Numerator: 3386. Numerator: 89. Numerator: 190. Numerator: 3639. Numerator: 4201. Numerator: 4078. Numerator: 123. Numerator: 2695. Numerator: 1023. Numerator: 3178. Numerator: 3823. Numerator: 107. Numerator: 271. Numerator: 7278. Numerator: 8438. Numerator: 3639. Numerator: 4237. Numerator: 4059. Numerator: 178. Numerator: 2974. Numerator: 1058. Numerator: 3179. Numerator: 3896. Numerator: 68. Numerator: 273. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Module: TB care and prevention. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 793; Denominator: 3776; Percentage: 21%. Numerator: 19; Denominator: 2492; Percentage: 0.76%. Numerator: 19; Denominator: 2492; Percentage: 0.76%. Numerator: 19; Denominator: 2492; Percentage: 0.76%. Numerator: 19; Denominator: 2492; Percentage: 0.76%. Numerator: 19; Denominator: 2492; Percentage: 0.76%. Numerator: 598.77; Denominator: 1088.67; Percentage: 55%. Numerator: 846; Denominator: 1089; Percentage: 77.7%. Numerator: 862; Denominator: 1161; Percentage: 74.2%. Numerator: 1197.8; Denominator: 2177.7; Percentage: 55%. Numerator: 1497; Denominator: 2246; Percentage: 66.7%. Numerator: 598.96; Denominator: 1089.02; Percentage: 55%. Numerator: 651; Denominator: 1157; Percentage: 56.3%. Numerator: 820.84; Denominator: 1172.63; Percentage: 70%. Numerator: 668; Denominator: 1173; Percentage: 57%. Numerator: 668. Numerator: 1641.6; Denominator: 2345.2; Percentage: 70%. Numerator: 1406; Denominator: 2137; Percentage: 65.8%. Numerator: 820.84; Denominator: 1172.63; Percentage: 70%. Numerator: 738; Denominator: 964; Percentage: 76.6%. Numerator: 738. Numerator: 1005.82; Denominator: 1257.27; Percentage: 80%. Numerator: 824; Denominator: 845; Percentage: 97.5%. Numerator: 824. Numerator: 2011.6; Denominator: 2514.6; Percentage: 80%. Numerator: 1541; Denominator: 1613; Percentage: 95.5%. Numerator: 1005.82; Denominator: 1257.27; Percentage: 80%. Numerator: 717; Denominator: 768; Percentage: 93.4%. Numerator: 717. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Module: TB care and prevention. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 89; Denominator: 106. Numerator: 109; Denominator: 115. Numerator: 105; Denominator: 119. Numerator: 109; Denominator: 115. Numerator: 104; Denominator: 113. Numerator: 109; Denominator: 115. Numerator: 105; Denominator: 119. Numerator: 115; Denominator: 121. Numerator: 58; Denominator: 113. Numerator: 121; Denominator: 128. Numerator: 90; Denominator: 95. Numerator: 121; Denominator: 128. Numerator: 90; Denominator: 95. Numerator: 134; Denominator: 140. Numerator: 101; Denominator: 105. Numerator: 129; Denominator: 135. Numerator: 82; Denominator: 96. Numerator: 134; Denominator: 140. Numerator: 101; Denominator: 105. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative> Module: TB care and prevention. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 1180; Denominator: 4918. Numerator: 1575.5; Denominator: 3151. Numerator: 1653; Denominator: 3137. Numerator: 3151.5; Denominator: 6303. Numerator: 3197; Denominator: 6739. Numerator: 1576; Denominator: 3152. Numerator: 1544; Denominator: 3602. Numerator: 2375.8; Denominator: 3394. Numerator: 1130; Denominator: 3121. Numerator: 4751.6; Denominator: 6788. Numerator: 3515; Denominator: 6786. Numerator: 2375.8; Denominator: 3394. Numerator: 2385; Denominator: 3665. Numerator: 3093.15; Denominator: 3639. Numerator: 2692; Denominator: 4201. Numerator: 6186.4; Denominator: 7278. Numerator: 5848; Denominator: 8438. Numerator: 3093.15; Denominator: 3639. Numerator: 3156; Denominator: 4237. <narrative>TCP-other 1: Proportion of TB patients in CDTs in areas facing insecurity put on anti-TB treatment</narrative> Module: TB care and prevention. <narrative>TCP-other 1: Proportion of TB patients in CDTs in areas facing insecurity put on anti-TB treatment</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 1469; Denominator: 1469. Numerator: 736; Denominator: 736. Numerator: 737; Denominator: 737. Numerator: 1472; Denominator: 1472. Numerator: 1545; Denominator: 1545. Numerator: 736; Denominator: 736. Numerator: 808; Denominator: 808. Numerator: 792; Denominator: 792. Numerator: 551; Denominator: 551. Numerator: 1584; Denominator: 1584. Numerator: 1889; Denominator: 1889. Numerator: 792; Denominator: 792. Numerator: 1338; Denominator: 1338. Numerator: 849; Denominator: 849. Numerator: 607; Denominator: 607. Numerator: 1698; Denominator: 1698. Numerator: 1233; Denominator: 1233. Numerator: 849; Denominator: 849. Numerator: 626; Denominator: 626. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Module: TB care and prevention. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 4917; Denominator: 5853. Numerator: 1701; Denominator: 2122. Numerator: 4117; Denominator: 5109. Numerator: 2416; Denominator: 2987. Numerator: 5078; Denominator: 6260. Numerator: 2316; Denominator: 2843. Numerator: 2762; Denominator: 3417. Numerator: 2763; Denominator: 3335. Numerator: 5799; Denominator: 7086. Numerator: 3036; Denominator: 3751. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 455; Denominator: 457. Numerator: 525.9; Denominator: 531.3. Numerator: 368; Denominator: 389. Numerator: 262.91; Denominator: 265.57. Numerator: 184; Denominator: 199. Numerator: 262.99; Denominator: 265.65. Numerator: 184; Denominator: 190. Numerator: 566.4; Denominator: 572. Numerator: 357; Denominator: 367. Numerator: 283.19; Denominator: 286.05. Numerator: 173; Denominator: 177. Numerator: 283.19; Denominator: 286.05. Numerator: 184; Denominator: 190. Numerator: 303.63; Denominator: 306.69. Numerator: 259; Denominator: 271. Numerator: 607.2; Denominator: 613.4. Numerator: 507; Denominator: 544. Numerator: 303.63; Denominator: 306.69. Numerator: 248; Denominator: 273. <narrative>Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative> Module: TB/HIV. <narrative>Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Percentage: 68.12%. Percentage: 68.12%. Percentage: 68.12%. Numerator: 896; Denominator: 8851; Percentage: 10.12%. Numerator: 1359; Denominator: 7768; Percentage: 17.5%. Numerator: 1641; Denominator: 7061; Percentage: 23.2%. Numerator: 388; Denominator: 3884; Percentage: 9.99%. Numerator: 1053; Denominator: 3639; Percentage: 28.9%. Numerator: 971; Denominator: 3884; Percentage: 25%. Numerator: 588; Denominator: 3422; Percentage: 17.2%. Numerator: 12. Numerator: 1386; Denominator: 3961; Percentage: 34.99%. Numerator: 1169; Denominator: 3557; Percentage: 32.9%. Numerator: 2. Numerator: 2772; Denominator: 7922; Percentage: 35%. Numerator: 2775; Denominator: 7199; Percentage: 38.5%. Numerator: 1386; Denominator: 3961; Percentage: 34.99%. Numerator: 1606; Denominator: 3642; Percentage: 44.1%. Numerator: 8; Denominator: 3642; Percentage: 0.22%. <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative> Module: TB/HIV. <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 5294; Denominator: 5916. Numerator: 3087.98; Denominator: 3151. Numerator: 2840; Denominator: 3137. Numerator: 6177; Denominator: 6303. Numerator: 6328; Denominator: 6739. Numerator: 3088.96; Denominator: 3152. Numerator: 3488; Denominator: 3602. Numerator: 6652.2; Denominator: 6788. Numerator: 6619; Denominator: 6786. Numerator: 3326.12; Denominator: 3394. Numerator: 3043; Denominator: 3121. Numerator: 3326.12; Denominator: 3394. Numerator: 3576; Denominator: 3665. Numerator: 3566.22; Denominator: 3639. Numerator: 4094; Denominator: 4201. Numerator: 7132.4; Denominator: 7278. Numerator: 8263; Denominator: 8438. Numerator: 3566.22; Denominator: 3639. Numerator: 4169; Denominator: 4237. 47045-BFA-T-PADS-4 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Scaling-up of high impact interventions in the fight against TB - Burkina Faso (01-Jan-2024-31-Dec-2026)</narrative> Burkina Faso, Tuberculosis, Programme d'Appui au Développement Sanitaire (PADS) Goal: Contribuer à l’amélioration de l’état de santé de la population du Burkina Faso en réduisant le poids de la tuberculose d’ici à fin 2026./ To contribute to the improvement of the health status of the population of Burkina Faso by reducing the burden of tuberculosis by the end of 2026. Objectives: Réduire l’incidence de la tuberculose de 45 en 2021 à 36 cas/100 000 habitants en 2026 / Reduce the incidence of tuberculosis from 45 in 2021 to 36 cases/100,000 inhabitants in 2026; Reduire le taux de mortalité de la tuberculose de 6,4 en 2021 à 5,5 décès/100 000 habitants d’ici à fin 2026 / Reduce the mortality rate of tuberculosis from 6.4 in 2021 to 5.5 deaths/100,000 inhabitants by the end of 2026; Accroître le taux de succès au traitement des patients TB pharmaco sensibles de 81,5% (cohorte 2020) à au moins 90% (cohorte 2025) et ceux TB-résistante de 75% (cohorte 2020) à au moins 80% (cohorte 2025) / Increase the treatment success rate of drug-susceptible TB patients from 81.5% (2020 cohort) to at least 90% (2025 cohort) and drug-resistant TB from 75% (2020 cohort) to at least 80% (2025 cohort). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Lilian Pedrosa Fund Portfolio Manager +41 58 791 1700 lilian.pedrosa@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Burkina Faso Tuberculosis Multicomponent, RSSH Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage Multicomponent -> Program management -> Coordination and management of national disease control programs Multicomponent -> Program management -> Grant management RSSH -> RSSH: Monitoring and evaluation systems -> Analyses, evaluations, reviews and data use RSSH -> RSSH: Monitoring and evaluation systems -> Routine reporting RSSH -> RSSH: Monitoring and evaluation systems -> Surveillance for HIV, tuberculosis and malaria RSSH -> RSSH: Monitoring and evaluation systems -> Surveys Tuberculosis -> Collaboration with other providers and sectors -> Community-based TB/DR-TB care Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB diagnosis/drug susceptibility testing (DST) Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB treatment, care and support Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Children and adolescents Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Miners and mining communities Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Mobile population (migrants/refugees/IDPs) Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Others Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - People in prisons/jails/detention centers Tuberculosis -> Removing human rights and gender related barriers to TB services -> Ensuring people-centered and rights-based TB services at health facilities Tuberculosis -> TB diagnosis, treatment and care -> TB screening and diagnosis Tuberculosis -> TB diagnosis, treatment and care -> TB treatment, care and support Tuberculosis -> TB/DR-TB Prevention -> Infection prevention and control (IPC) Tuberculosis -> TB/HIV -> TB/HIV - Prevention Tuberculosis -> TB/HIV -> TB/HIV - Screening, testing and diagnosis Tuberculosis -> TB/HIV -> TB/HIV - Treatment and care 2194983.23 3433790.00 2135036.05 4074589.73 Global Fund commitment to BFA-T-PADSP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 137628.03 Global Fund disbursement to BFA-T-PADSP04 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 358087.46 Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 28577.90 Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 393997.34 Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 26696.93 Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 632177.01 Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 260395.43 Global Fund disbursement to BFA-T-PADSP04 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 378621.02 Global Fund disbursement to BFA-T-PADSP04 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 183.58 Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -183.58 Global Fund commitment to BFA-T-PADSP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 1143983.88 Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 188440.59 Global Fund disbursement to BFA-T-PADSP04 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 989.36 Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -989.36 Global Fund commitment to BFA-T-PADSP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 73987.73 Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 3151.03 Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria 22564.38 Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -22564.38 Global Fund commitment to BFA-T-PADSP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -3151.03 Global Fund commitment to BFA-T-PADSP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -451996.40 Global Fund commitment to BFA-T-PADSP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 1817733.17 Global Fund commitment to BFA-T-PADSP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 620786.63 Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 31212.29 Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -31212.29 Global Fund commitment to BFA-T-PADSP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 697365.13 Global Fund commitment to BFA-T-PADSP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 697365.13 Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 7166.89 Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 7142.61 Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 25487.15 Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -25487.15 Global Fund commitment to BFA-T-PADSP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 22079.13 Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 207428.53 Global Fund commitment to BFA-T-PADSP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 4221.54 Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria 1071.10 Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -4221.54 Global Fund commitment to BFA-T-PADSP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -1071.10 Global Fund commitment to BFA-T-PADSP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 88.60 Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -88.60 Global Fund commitment to BFA-T-PADSP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 893508.76 Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 11821.66 Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 98567.98 Global Fund disbursement to BFA-T-PADSP04 (Pooled Procurement Mechanism). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 187399.23 Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 18742.09 Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria 835287.82 Global Fund commitment to BFA-T-PADSP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -67828.28 Global Fund commitment to BFA-T-PADSP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -18742.09 Global Fund commitment to BFA-T-PADSP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 437871.03 Global Fund disbursement to BFA-T-PADSP04 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 33662.53 Global Fund disbursement to BFA-T-PADSP04 (Pooled Procurement Mechanism). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 1561.77 Global Fund disbursement to BFA-T-PADSP04 (Pooled Procurement Mechanism). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 24675.97 Funds returned to the Global Fund from BFA-T-PADSP04 (Other 3rd Party). Programme d'Appui au Développement Sanitaire (PADS) The Global Fund to Fight AIDS, Tuberculosis and Malaria -24675.97 Global Fund commitment to BFA-T-PADSP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) -73636.25 Global Fund commitment to BFA-T-PADSP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 14875.29 Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 26279.59 Global Fund disbursement to BFA-T-PADSP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Programme d'Appui au Développement Sanitaire (PADS) 2194983.23 Expenditure reported by Programme d'Appui au Développement Sanitaire (PADS) for BFA-T-PADSP04, Jan 2024 to Dec 2024. Programme d'Appui au Développement Sanitaire (PADS) 2554792.00 Expenditure reported by Programme d'Appui au Développement Sanitaire (PADS) for BFA-T-PADSP04, Jan 2025 to Dec 2025. Programme d'Appui au Développement Sanitaire (PADS) <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>2023 - Funding Request - Window 1 - Multicomponent - Burkina Faso - English</narrative> Funding Request of funding request FR1537-BFA-Z. <narrative>2023 - Funding Request - Window 1 - Multicomponent - Burkina Faso - Français</narrative> Funding Request of funding request FR1537-BFA-Z. 1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons. 2 - With respect to Section 7.6 (Right of Access) of the Global Fund Grant Regulations (as amended from time to time), (1) the Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data, and (2), prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any applicable law or regulation. 3 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of EUR 1,574,256 (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction of the Grantee’s compliance with the requirements listed at 6.3(1)(a) and 6.3(1)(b) below (“Co-Financing Requirements”). The Principal Recipient acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Grantee fails to: (a) maintain government expenditure on health to meet national universal health coverage goals; and/or (b) maintain domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee shall, as set out in the Commitment Letter dated 19 March 2023 (the “Commitment Letter”), unless otherwise agreed in writing by the Global Fund: (a) fulfil a total minimum co-financing commitment of EUR 128,937,898 from 2024 to 2026 (inclusive), comprising investments in: i. tuberculosis of EUR 2,127,333; and ii. RSSH of EUR 126,810,565; (b) fulfil the programmatic commitments as stipulated in Section 1.3 of the Commitment Letter; and (c) provide to the Global Fund, by no later than 30 June and 15 August of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including: i. the approved annual budget for the specific tuberculosis Budget lines for the upcoming year; and ii. the total expenditure for the specific tuberculosis Budget lines in the previous fiscal year. 4 - The Program budget may be funded in part by Grant Funds disbursed under a previous Grant Agreement, which the Global Fund has approved to be used for the Program under the current Grant Agreement (“Previously Disbursed Grant Funds”), as well as additional Grant Funds up to the amount set forth in Section 3.6. hereof. Accordingly, the Global Fund may reduce the amount of Grant Funds set forth in Section 3.6. hereof by the amount of any Previously Disbursed Grant Funds. Previously Disbursed Grant Funds shall be governed by the terms of this Grant Agreement. 5 - (1) Grant Funds may be used to pay for services performed by a fiscal agent retained by the Global Fund (the “Fiscal Agent”) and the Global Fund may disburse such Grant Funds directly to the Fiscal Agent; (2) The Principal Recipient consents to the terms of reference of the Fiscal Agent and agrees that such terms of reference may be amended from time to time at the Global Fund’s discretion; (3) The Principal Recipient shall take all necessary actions under applicable laws, regulations, rules and procedures to grant to the Fiscal Agent co-signature authority to all bank accounts of the Principal Recipient in which Grant Funds are held (“Program Accounts”) and give full effect thereto, and shall provide evidence thereof to the Global Fund upon request. The Principal Recipient shall not change any Program Account without the Global Fund’s prior written approval, which shall be subject, among others, to receipt by the Global Fund of evidence of co-signature authority pursuant to the immediately preceding sentence; (4) The Principal Recipient shall cooperate fully with the Fiscal Agent to allow the Fiscal Agent to perform its services, including, but not limited to, by (a) providing all information requested by the Fiscal Agent or the Global Fund; (b) taking all necessary actions prior to collection of Personal Data and at all times thereafter to ensure that the processing of Personal Data by the Fiscal Agent does not violate any applicable law or regulation; and (c) implementing any recommendations made by the Fiscal Agent; and (5) The appointment of the Fiscal Agent shall not, nor shall it be construed to, discharge the Grantee nor the Principal Recipient of their respective obligations under the Grant Agreement, which shall remain in full force and effect. The Fiscal Agent shall not have authority to act as the Global Fund’s agent, unless provided otherwise in writing by the Global Fund. Accordingly, the Global Fund reserves the right to classify any expenditure of Grant Funds as non-compliant, notwithstanding its verification or endorsement by the Fiscal Agent. 6 - The procurement of Health Products shall be carried out through the Pooled Procurement Mechanism (“PPM”) of the Global Fund, unless the Global Fund directs the Principal Recipient otherwise in writing. The Principal Recipient has all the necessary power and authority to execute, deliver and carry out its obligations under the wambo.org – PPM registration letter in the form approved by the Global Fund. 7 - (1) Grant Funds may be used to pay for the services of an external auditor or for a Supreme Audit Institution approved by the Global Fund retained by the Global Fund for the annual independent audit of the Program (the “External Auditor”) and the Global Fund may disburse such Grant Funds directly to the External Auditor; (2) the Principal Recipient shall consent, no later than 30 March 2024, to the carrying out of audits of the Program by the External Auditor for the period covering fiscal years 2024, 2025 and 2026 (and other such additional periods as the Global Fund may communicate to the Principal Recipient in writing, and to the terms of reference of the External Auditor and agrees that such terms of reference may be amended from time to time; and (3) without limiting Section 7.5 of the Global Fund Grant Regulations (as amended from time to time), the Principal Recipient shall cooperate fully with the External Auditor to allow the External Auditor to perform its services, including by providing all information and documents requested by the External Auditor or the Global Fund. 8 - Unless otherwise notified by the Global Fund in writing, prior to the use of Grant Funds to finance the procurement of second-line anti-tuberculosis drugs and for each disbursement request that includes funds for the procurement of multi-drug resistant tuberculosis medicines, the Principal Recipient shall submit to the Global Fund and obtain the Global Fund’s written approval of a written confirmation of the price estimate and quantities of the second-line anti-tuberculosis drugs that will be procured by the Principal Recipient from the Global Drug Facility’s procurement agent. 9 - The Global Fund may disburse Grant Funds in a currency other than that specified in the Grant Confirmation. In such cases, the exchange rate used to calculate the amount of the disbursement into its equivalent in the currency specified in the Grant Confirmation shall be the relevant exchange rate reflected in the Program budget. 10 - By no later than 15 January 2024, the Grantee shall sign the Protocol for repayment with the Global Fund shared on 20 October 2023 and comply with the reimbursement schedule set out in Section 1.2 of the Protocol. In the event that the Global Fund does not receive the payments scheduled to be made under the Protocol between the Grantee and the Global Fund by 1 February 2024, the Global Fund may, at its sole discretion, and at any time during the Implementation Period, reduce the amount of Grant Funds under this Grant Agreement. <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 66; Denominator: 77; Percentage: 85.71%. Numerator: 68; Denominator: 77; Percentage: 88.31%. Numerator: 68; Denominator: 77; Percentage: 88.31%. Numerator: 0; Denominator: 77; Percentage: 0%. Numerator: 0; Denominator: 77; Percentage: 0%. Numerator: 11; Denominator: 77; Percentage: 14.29%. Numerator: 11; Denominator: 77; Percentage: 14.29%. Numerator: 2; Denominator: 77; Percentage: 2.6%. Numerator: 2; Denominator: 77; Percentage: 2.6%. Numerator: 57; Denominator: 77; Percentage: 74.03%. Numerator: 57; Denominator: 77; Percentage: 74.03%. Numerator: 66; Denominator: 77; Percentage: 85.71%. Numerator: 66; Denominator: 77; Percentage: 85.71%. Percentage: 100%. Percentage: 100%. Numerator: 106; Denominator: 121; Percentage: 87.6%. Percentage: 100%. Numerator: 64; Denominator: 79; Percentage: 81.01%. Numerator: 48; Denominator: 54; Percentage: 88.89%. Numerator: 3; Denominator: 3; Percentage: 100%. Numerator: 10; Denominator: 51; Percentage: 19.61%. Numerator: 3. Numerator: 41; Denominator: 51; Percentage: 80.39%. Numerator: 48. Percentage: 100%. Percentage: 100%. Numerator: 79; Denominator: 85; Percentage: 92.94%. Percentage: 100%. Numerator: 41; Denominator: 41; Percentage: 100%. Numerator: 37; Denominator: 38; Percentage: 97.37%. Numerator: 3; Denominator: 3; Percentage: 100%. Numerator: 9; Denominator: 9; Percentage: 100%. Numerator: 0. Numerator: 31; Denominator: 32; Percentage: 96.88%. Numerator: 0. Percentage: 100%. Percentage: 100%. <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 44; Denominator: 82; Percentage: 53.66%. Numerator: 44; Denominator: 82; Percentage: 53.66%. Numerator: 44; Denominator: 82; Percentage: 53.66%. Numerator: 0; Denominator: 82; Percentage: 0%. Numerator: 0; Denominator: 82; Percentage: 0%. Numerator: 7; Denominator: 82; Percentage: 8.54%. Numerator: 7; Denominator: 82; Percentage: 8.54%. Numerator: 2; Denominator: 82; Percentage: 2.44%. Numerator: 2; Denominator: 82; Percentage: 2.44%. Numerator: 37; Denominator: 82; Percentage: 45.12%. Numerator: 37; Denominator: 82; Percentage: 45.12%. Numerator: 39; Denominator: 82; Percentage: 47.56%. Numerator: 39; Denominator: 82; Percentage: 47.56%. Numerator: 5; Denominator: 82; Percentage: 6.1%. Numerator: 5; Denominator: 82; Percentage: 6.1%. Numerator: 5; Denominator: 82; Percentage: 6.1%. Numerator: 5; Denominator: 82; Percentage: 6.1%. Numerator: 39; Denominator: 82; Percentage: 47.56%. Numerator: 39; Denominator: 82; Percentage: 47.56%. Numerator: 42; Denominator: 82; Percentage: 51.22%. Numerator: 42; Denominator: 82; Percentage: 51.22%. Numerator: 0; Denominator: 82; Percentage: 0%. Numerator: 0; Denominator: 82; Percentage: 0%. Percentage: 73.4%. Numerator: 69; Denominator: 112; Percentage: 61.61%. Percentage: 73.4%. Percentage: 73.4%. Numerator: 26; Denominator: 42; Percentage: 61.9%. Numerator: 28; Denominator: 56; Percentage: 50%. Numerator: 1; Denominator: 1; Percentage: 100%. Numerator: 8; Denominator: 12; Percentage: 66.67%. Numerator: 1. Numerator: 21; Denominator: 45; Percentage: 46.67%. Numerator: 28; Denominator: 49; Percentage: 57.14%. Numerator: 1; Denominator: 5; Percentage: 20%. Numerator: 0; Denominator: 0. Numerator: 29; Denominator: 57; Percentage: 50.88%. Numerator: 28. Numerator: 0; Denominator: 2. Percentage: 76.77%. Percentage: 76.8%. Numerator: 48; Denominator: 71; Percentage: 67.61%. Percentage: 76.77%. Numerator: 23; Denominator: 34; Percentage: 67.65%. Numerator: 0; Denominator: 0. Numerator: 0; Denominator: 0. Numerator: 0; Denominator: 0. Numerator: 0. Numerator: 0; Denominator: 0. Numerator: 0; Denominator: 0. Numerator: 1; Denominator: 4; Percentage: 25%. Numerator: 0; Denominator: 0. Numerator: 23; Denominator: 34; Percentage: 67.65%. Numerator: 0. Numerator: 0; Denominator: 0. Percentage: 80.39%. Percentage: 80.39%. <narrative>Number of people with TB (all forms) notified among key affected populations/high risk groups (other than prisoners); *includes only those with new and relapse</narrative> Module: Key and vulnerable populations (KVP) - TB/DR-TB. <narrative>Number of people with TB (all forms) notified among key affected populations/high risk groups (other than prisoners); *includes only those with new and relapse</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative> Module: Key and vulnerable populations (KVP) - TB/DR-TB. <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> Module: TB diagnosis, treatment and care. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 3903; Denominator: 7320; Percentage: 53.32%. Numerator: 190; Denominator: 7320; Percentage: 2.6%. Numerator: 190; Denominator: 7320; Percentage: 2.6%. Numerator: 3713; Denominator: 7320; Percentage: 50.72%. Numerator: 3713; Denominator: 7320; Percentage: 50.72%. Percentage: 70%. Percentage: 70%. Numerator: 5370; Denominator: 9308; Percentage: 57.69%. Percentage: 70%. Numerator: 2592; Denominator: 4572; Percentage: 56.69%. Numerator: 139. Numerator: 2453. Percentage: 80%. Numerator: 7001; Denominator: 10304; Percentage: 67.94%. Percentage: 80%. Percentage: 80%. Numerator: 3735; Denominator: 5194; Percentage: 71.91%. Numerator: 114. Numerator: 3621. Percentage: 90%. Percentage: 90%. <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 2305; Denominator: 7320. Numerator: 1027; Denominator: 9308. Numerator: 406; Denominator: 4572. Numerator: 1024; Denominator: 10304. Numerator: 644; Denominator: 5194. <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 5461; Denominator: 6716. Numerator: 6883; Denominator: 8494. Numerator: 3931; Denominator: 4860. Numerator: 7780; Denominator: 9230. Numerator: 3929; Denominator: 4579. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Module: TB/DR-TB Prevention. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 386; Denominator: 395. Numerator: 466; Denominator: 468. Numerator: 202; Denominator: 208. Numerator: 518; Denominator: 522. Numerator: 258; Denominator: 259. <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative> Module: TB/HIV. <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 1665; Denominator: 78511; Percentage: 2.12%. Numerator: 588; Denominator: 3802; Percentage: 15.47%. Numerator: 588; Denominator: 3802; Percentage: 15.47%. Numerator: 12; Denominator: 3802; Percentage: 0.32%. Numerator: 12; Denominator: 3802; Percentage: 0.32%. Numerator: 478; Denominator: 3802; Percentage: 12.57%. Numerator: 478; Denominator: 3802; Percentage: 12.57%. Numerator: 75; Denominator: 3802; Percentage: 1.97%. Numerator: 75; Denominator: 3802; Percentage: 1.97%. Numerator: 23; Denominator: 3802; Percentage: 0.6%. Numerator: 23; Denominator: 3802; Percentage: 0.6%. Numerator: 403; Denominator: 3802; Percentage: 10.6%. Numerator: 403; Denominator: 3802; Percentage: 10.6%. Numerator: 185; Denominator: 3802; Percentage: 4.87%. Numerator: 185; Denominator: 3802; Percentage: 4.87%. Numerator: 10770; Denominator: 86600; Percentage: 12.4%. Numerator: 9338; Denominator: 59908; Percentage: 15.59%. Numerator: 5385; Denominator: 86600; Percentage: 6.22%. Numerator: 5385; Denominator: 86600; Percentage: 6.22%. Numerator: 5355; Denominator: 59908; Percentage: 8.94%. Numerator: 5201. Numerator: 639. Numerator: 3622. Numerator: 733. Numerator: 361. Numerator: 3747. Numerator: 1608. Numerator: 18254; Denominator: 86392; Percentage: 21.1%. Numerator: 13817; Denominator: 87534; Percentage: 15.78%. Numerator: 9127; Denominator: 86392; Percentage: 10.56%. Numerator: 9127; Denominator: 86392; Percentage: 10.56%. Numerator: 7400; Denominator: 87534; Percentage: 8.45%. Numerator: 13548. Numerator: 304. Numerator: 4451. Numerator: 2026. Numerator: 619. Numerator: 9946. Numerator: 3871. Numerator: 9580; Denominator: 86360; Percentage: 11.09%. Numerator: 9579; Denominator: 86360; Percentage: 11.09%. <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative> Module: TB/HIV. <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 7945; Denominator: 7945; Percentage: 100%. Numerator: 7406; Denominator: 7406; Percentage: 100%. Numerator: 7406; Denominator: 7406; Percentage: 100%. Numerator: 283; Denominator: 283; Percentage: 100%. Numerator: 283; Denominator: 283; Percentage: 100%. Numerator: 256; Denominator: 256; Percentage: 100%. Numerator: 256; Denominator: 256; Percentage: 100%. Numerator: 5321; Denominator: 5321; Percentage: 100%. Numerator: 5321; Denominator: 5321; Percentage: 100%. Numerator: 2524; Denominator: 2624; Percentage: 96.19%. Numerator: 2524; Denominator: 2624; Percentage: 96.19%. Percentage: 100%. Percentage: 100%. Numerator: 22168; Denominator: 7726; Percentage: 286.93%. Percentage: 100%. Numerator: 8085; Denominator: 3877; Percentage: 208.54%. Numerator: 7523. Numerator: 368. Numerator: 162. Numerator: 5384. Numerator: 2669. Percentage: 100%. Numerator: 6779; Denominator: 6853; Percentage: 98.92%. Percentage: 100%. Percentage: 100%. Numerator: 3507; Denominator: 3557; Percentage: 98.59%. Numerator: 6426. Numerator: 141. Numerator: 212. Numerator: 4603. Numerator: 2176. Percentage: 100%. Percentage: 100%. <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative> Module: TB/HIV. <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 7146; Denominator: 7320; Percentage: 97.62%. Numerator: 6751; Denominator: 7320; Percentage: 92.23%. Numerator: 6751; Denominator: 7320; Percentage: 92.23%. Numerator: 395; Denominator: 7320; Percentage: 5.4%. Numerator: 395; Denominator: 7320; Percentage: 5.4%. Numerator: 174; Denominator: 7320; Percentage: 2.38%. Numerator: 174; Denominator: 7320; Percentage: 2.38%. Percentage: 98%. Numerator: 8792; Denominator: 9308; Percentage: 94.46%. Percentage: 98%. Percentage: 98%. Numerator: 4277; Denominator: 4572; Percentage: 93.55%. Numerator: 3995. Numerator: 208. Numerator: 74. Percentage: 98%. Numerator: 10154; Denominator: 10304; Percentage: 98.54%. Percentage: 98%. Percentage: 98%. Numerator: 5177; Denominator: 5194; Percentage: 99.67%. Numerator: 4640. Numerator: 259. Numerator: 278. Percentage: 99%. Percentage: 99%.